Join Ligand Pharmaceuticals for its annual Investor Day featuring presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of the Ligand senior management team. Presentations will highlight the Company’s strategy, investment activity, royalty portfolio, and long-term financial outlook. Scott Plesha, CEO of Pelthos Therapeutics (NYSE American: PTHS), a Ligand partner, will be a guest speaker at the event and will discuss the recent launch of ZELSUVMI™ (berdazimer) topical gel 10.3%, the first and only FDA-approved at-home treatment for molluscum contagiosum.

A live question and answer session will follow the formal presentations.